Evaluation of the treatment of equine glandular gastric disease with either long‐acting‐injectable or oral omeprazole
Sign Up to like & getrecommendations! Published in 2022 at "Veterinary Medicine and Science"
DOI: 10.1002/vms3.728
Abstract: Abstract Background Equine glandular gastric disease (EGGD) is common in domesticated horses and can be challenging to treat. Oral omeprazole (ORLO) is used widely but the clinical response is frequently poor. Objectives To compare rates… read more here.
Keywords: equine glandular; glandular gastric; acting injectable; long acting ... See more keywords
Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of clinical pharmacology"
DOI: 10.1007/s00228-022-03304-3
Abstract: PURPOSE To investigate the suitability of microdosed oral omeprazole for predicting CYP2C19 activity in vivo in combination with simultaneous assessment of CYP3A and CYP2D6 activity using both microdosed midazolam and yohimbine. METHODS An open, fixed-sequence… read more here.
Keywords: oral omeprazole; cyp2c19 activity; microdosed oral; activity ... See more keywords
Effect of Laparoscopic Sleeve Gastrectomy on the Pharmacokinetics of Oral Omeprazole Using a Population Approach
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14101986
Abstract: Omeprazole is commonly prescribed to obese patients and patients after laparoscopic sleeve gastrectomy (LSG). The pharmacokinetics of oral omeprazole after LSG are still unknown. Therefore, the aim of this study was to investigate the pharmacokinetics… read more here.
Keywords: pharmacokinetics oral; laparoscopic sleeve; lsg; oral omeprazole ... See more keywords